Centene Stock Forecast for 2023 - 2025 - 2030

Updated on 02/28/2024

Stock Rating
11
Price Target
$90.00
Consensus
Outperform
Upside
11.93%
Analysts
11
Stock Rating
11
Upside
11.93%
Analysts
11
Price Target
$90.00

Centene Stock Forecast and Price Target

If Centene's stock price reached the average yearlong target of $90.00 given by eleven well-known analysts in recent months, there would be a potential upside of approximately 11.93% from its last closing price in February, 2024. This potential increase is based on a high estimate of $110.00 and a low estimate of $73.30. If interested in CNC stock, you may also want to consider its competitors.

$90.00

11.93% Upside

Outperform
Outperform

Centene Fair Value Forecast for 2023 - 2025 - 2030

Centene's Price has decreased by 100.00% In the last four years, from $66.35 to $0.00. In the next year, analysts believe that Fair Value will reach $101.52 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$101.52
2025 Fair Value Forecast
$112.80
2026 Fair Value Forecast
$124.47
2027 Fair Value Forecast
$137.48
2028 Fair Value Forecast
$152.47
2029 Fair Value Forecast
$169.19
2030 Fair Value Forecast
$186.05
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
UNH Stock Forecast UnitedHealth Group Outperform 16
$513.42 Buy/Sell $595.09 16.86%
ELV Stock Forecast Elevance Health Buy 14
$507.41 Buy/Sell $567.53 13.32%
CI Stock Forecast The Cigna Group Outperform 12
$340.74 Buy/Sell $354.48 9.17%
CVS Stock Forecast CVS Health Outperform 12
$76.27 Buy/Sell $89.54 15.38%
HCA Stock Forecast HCA Healthcare Outperform 18
$314.00 Buy/Sell $319.61 5.10%

Centene Revenue Forecast for 2023 - 2025 - 2030

Centene's Revenue has seen impressive growth In the last three years, rising from $104.18B to $141.27B – a growth of 35.60%. In the next year, analysts believe that Revenue will reach $149.98B – an increase of 6.17%. For the next seven years, the forecast is for Revenue to grow by 34.13%.

2024 Rev Forecast
$149.98B
2025 Rev Forecast
$149.65B
2026 Rev Forecast
$155.95B
2027 Rev Forecast
$165.64B
2028 Rev Forecast
$173.92B
2029 Rev Forecast
$181.53B
2030 Rev Forecast
$189.48B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HUM Stock Forecast Humana Outperform 14
$362.70 Buy/Sell $426.74 14.42%
CAH Stock Forecast Cardinal Health Inc Hold 13
$109.61 Buy/Sell $108.07 4.92%
MOH Stock Forecast Molina Healthcare Outperform 16
$400.12 Buy/Sell $393.38 3.72%

Centene Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
UHS Stock Forecast Universal Health Services Outperform 6
$165.79 Buy/Sell $162.38 -2.89%
DVA Stock Forecast DaVita Inc Hold 16
$127.60 Buy/Sell $108.38 -2.23%
THC Stock Forecast Tenet Healthcare Outperform 15
$90.23 Buy/Sell $86.63 16.37%

Centene Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$5.07B
2025 FCF Forecast
$5.03B
2026 FCF Forecast
$5.32B
2027 FCF Forecast
$5.42B
2028 FCF Forecast
$5.55B
2029 FCF Forecast
$5.76B
2030 FCF Forecast
$6.03B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CHE Stock Forecast Chemed Corp Buy 18
$596.60 Buy/Sell $611.33 4.76%
ACHC Stock Forecast Acadia Healthcare Company Outperform 15
$87.38 Buy/Sell $89.55 5.29%
EHC Stock Forecast Encompass Health Buy 18
$75.34 Buy/Sell $84.00 12.82%

Centene EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Centene's EBITDA has seen an increase, rising from $5.37B to $6.08B. This represents a growth of 13.22%. Analysts predict that Centene's EBITDA will increase in the upcoming year, reaching $7.25B. This would represent an increase of 19.24%. Over the next seven years, experts predict that Centene's EBITDA will grow at a rate of 7.66%.

2024 EBITDA Forecast
$7.25B
2025 EBITDA Forecast
$6.30B
2026 EBITDA Forecast
$6.50B
2027 EBITDA Forecast
$6.41B
2028 EBITDA Forecast
$6.70B
2029 EBITDA Forecast
$6.56B
2030 EBITDA Forecast
$6.54B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ENSG Stock Forecast The Ensign Group Outperform 18
$123.93 Buy/Sell $119.25 6.11%
OPCH Stock Forecast Option Care Health Buy 14
$32.76 Buy/Sell $0.00 16.00%
SGRY Stock Forecast Surgery Partners Buy 13
$31.84 Buy/Sell $43.20 36.62%

Centene EBIT Forecast for 2023 - 2025 - 2030

Centene's EBIT has seen growth In the last three years, going from $4.11B to $4.79B – a gain of 16.45% In the next year, analysts believe that EBIT will reach $6.08B – an increase of 27.06%. For the next seven years, the forecast is forEBIT to grow by 51.50%.

2024 EBIT Forecast
$6.08B
2025 EBIT Forecast
$5.12B
2026 EBIT Forecast
$5.49B
2027 EBIT Forecast
$5.98B
2028 EBIT Forecast
$6.42B
2029 EBIT Forecast
$6.84B
2030 EBIT Forecast
$7.25B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SEM Stock Forecast Select Medical Holdings Outperform 16
$27.92 Buy/Sell $32.80 28.94%
AMED Stock Forecast Amedisys Hold 16
$93.14 Buy/Sell $97.00 8.44%
AMN Stock Forecast AMN Healthcare Services Outperform 16
$54.89 Buy/Sell $86.13 41.19%

Centene EPS Price Prediction Forecast for 2023 - 2025 - 2030

Centene's EPS has decreased by 100.00% In the last four years, from $5.00 to $0.00. In the next year, analysts believe that EPS will reach $7.65 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$7.65
2025 EPS Forecast
$8.50
2026 EPS Forecast
$9.38
2027 EPS Forecast
$10.36
2028 EPS Forecast
$11.49
2029 EPS Forecast
$12.75
2030 EPS Forecast
$14.02
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BKD Stock Forecast Brookdale Senior Living Outperform 10
$5.91 Buy/Sell $6.48 31.13%
MD Stock Forecast Pediatrix Medical Group Hold 12
$9.01 Buy/Sell $9.86 -0.11%
CYH Stock Forecast Community Health Systems Outperform 11
$2.76 Buy/Sell $4.98 81.16%